(0.20%) 5 142.00 points
(0.21%) 38 520 points
(0.26%) 17 892 points
(-0.92%) $83.08
(1.61%) $1.954
(-0.14%) $2 344.00
(-0.13%) $27.50
(0.34%) $925.20
(-0.21%) $0.933
(-0.18%) $11.00
(-0.27%) $0.798
(1.18%) $92.96
3.56% CNY 14.84
Live Chart Being Loaded With Signals
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others...
Stats | |
---|---|
Volumen de hoy | 24.74M |
Volumen promedio | 19.14M |
Capitalización de mercado | 23.15B |
EPS | CNY0.0600 ( 2023-10-25 ) |
Last Dividend | CNY0 ( N/A ) |
Next Dividend | CNY0 ( N/A ) |
P/E | 92.75 |
ATR14 | CNY0.0160 (0.11%) |
Volumen Correlación
Walvax Biotechnology Co., Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Walvax Biotechnology Co., Correlación - Moneda/Commodity
Walvax Biotechnology Co., Finanzas
Annual | 2023 |
Ingresos: | CNY4.08B |
Beneficio Bruto: | CNY3.40B (83.25 %) |
EPS: | CNY0.260 |
FY | 2023 |
Ingresos: | CNY4.08B |
Beneficio Bruto: | CNY3.40B (83.25 %) |
EPS: | CNY0.260 |
FY | 2022 |
Ingresos: | CNY5.09B |
Beneficio Bruto: | CNY4.48B (88.02 %) |
EPS: | CNY0.460 |
FY | 2021 |
Ingresos: | CNY3.46B |
Beneficio Bruto: | CNY3.07B (88.61 %) |
EPS: | CNY0.273 |
Financial Reports:
No articles found.
Walvax Biotechnology Co.,
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as cerebrospinal meningitis and septicemia; Group A and C meningococcal polysaccharide vaccine for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium Neisseria meningitidis group A or group C; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis group A, C, Y, and W135. The company also offers haemophilus influenzae type b conjugate vaccine for children from the age of 2 months to 5 years for the prevention of infectious diseases, including meningitis, pneumonia, septicemia, cellulitis, arthritis, epiglottitis, etc. In addition, it provides diphtheria, tetanus, and acellular pertussis combined vaccine for the prevention of diphtheria, tetanus, and pertussis for individuals from the age of 3 months to 6 years; and 23-valent pneumococcal polysaccharide vaccine for children above 2 years old to prevent pneumococcal disease caused by 23 serotypes. Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, China.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico